Alesta Therapeutics

Acquired

Biotech

Alesta Therapeutics was founded in 2021, lists 11–50 employees, and has $75.8M in recorded funding across 1 round.

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$75.8M
Last Round
$75.8M Series AJan 2025
Rounds
1
Acquisition Date
Aug 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases. Its globally experienced team brings together diverse expertise to drive small molecule innovation, developing targeted and effective therapies for rare diseases where few options exist. With a patient-friendly approach, the company prioritizes safety, efficacy, and accessibility, and favors oral small molecules for delivery, scalability, and tissue penetration in chronic conditions.

Summary

Alesta Therapeutics is a Biotech company, founded in 2021. It lists 11–50 employees. It has raised $75.8M in total across 1 round, most recently a $75.8M Series A round in Jan 2025.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAug 2026

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alesta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alesta-therapeutics"><img src="https://indexed.vc/api/badge/company/alesta-therapeutics" alt="Alesta Therapeutics on Indexed.vc" width="260" height="76" /></a>